Forge Biologics released its first Bench Strength podcast episode featuring David Dismuke and Maritza McIntyre.
Public source
Publisher name
Public post
Mass photometry is gaining traction in AAV. But where does it fit alongside AUC? Brianna Barrett, Ph.D. breaks down the role of each in empty vs. full capsid characteriz…
Company
Forge Biologics
A member of Ajinomoto Bio-Pharma Services
- Industry
- Biotechnology Research
- Location
- Columbus, US
- Company size
- 201–500 employees
About Forge Biologics
Forge, a member of Ajinomoto Bio-Pharma Services, is a gene therapy development engine, focused on enabling access to life changing gene therapies and helping bring them from idea into reality. We partner with innovators in the gene therapy community: scientists, physicians, biotech/pharma companies, and patient groups. We bring expertise in gene therapy manufacturing and therapeutics development to the table, helping champion teams that are navigating the long road from the lab bench to the bedside. With a patients-first approach, we are forging new models for working together to better accelerate these transformative medicines to reach those who need them most.
See moreLatest activity
Latest activity from Forge Biologics
6 signals
Presence & Recognition
Forge Biologics is hosting a panel discussion titled Scaling Downstream Processes: From Lab to GMP Manufacturing on September 23rd at 2:00 PM EST in Boston
People
Forge Biologics is hiring a Director, Quality Control (Raw Materials) to drive strategic direction and tactical execution of QC Raw Materials.
Presence & Recognition
Forge Biologics announced its upcoming fall conference slate including stops in Phoenix for ARM's Meeting on the Mesa and Hamburg for the ESGCT annual meeting.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
Labshares
Labshares released Part 3 of The Biotech Startups Podcast featuring CEO Philip Borden
Presence & Recognition
Eurofins DiscoverX
Eurofins DiscoverX announced a podcast featuring discussions by Jane Lamerdin, Gaurav Agrawal, Ph.D., and Yamina Berchiche on the GPCR resurgence.
Presence & Recognition
BOOST Pharma
BOOST Pharma was featured on the BioHub podcast episode hosted by Max Brennan, MSc, discussing the strategy, culture, and future of BT-101 as it advances towards late-stage clinical development.
Presence & Recognition
Alloy Therapeutics, Inc.
Alloy Therapeutics, Inc. released a final video series on complex biologics and multispecifics antibody discovery.
Presence & Recognition
Form Bio